MedTrace Logo

Validation of a Proteomic Signature and Assessment of Viremia in Children With Fever Without Source

NCT03224026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2023-01-06

No results posted yet for this study

Summary

The study is an observational blinded Validation study in pediatric patients below 3 years old with a diagnosis of Fever Without Source (FWS). In this study the investigators aim to validate the performance of a proteomic signature aiding the physicians to discriminate between viral and bacterial infections in febrile children. The study will also assess the prevalence of Human Enteroviruses (HEV), Human Parechoviruses (HPeV), Adenovirus (AdV) and Human Herpesvirus type 6 (HHV-6) viremia, as well as Kingella Kingae bacteremia in the study cohort.

Conditions

Sponsors & Collaborators

  • University Hospital, Geneva

    collaborator OTHER

  • MeMed Diagnostics Ltd.

    lead INDUSTRY

Eligibility

Min Age
1 Day
Max Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-06-30
Completion
2018-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03224026 on ClinicalTrials.gov